Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.59 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.57 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6517636 | 1.00 | ESR1 (0.59) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL1652775 | 0.98 | CYP19A1 (0.59) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL987335 | 0.96 | ESR1 (0.64) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL14928213 | 0.96 | ESR1 (0.64) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL6675573 | 0.94 | ESR1 (0.53) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL6675575 | 0.94 | ESR1 (0.53) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL15607138 | 0.92 | CYP19A1 (0.53) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL21738730 | 0.91 | ESR1 (0.62) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL19660691 | 0.90 | ALDH1A1 (0.56) | ESR1CYP19A1CYP11B2ESR2PTGS2 | |
| SCHEMBL13026494 | 0.87 | MEN1 (0.49) | ESR1CYP19A1CYP11B2ESR2PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | IDEMITSU KOSAN CO., LTD (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1155096-B1 | FLUORENE COPOLYMERS AND DEVICES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES INC (US) | 2005-03-09 | — | — | EP | disclosed |
| US-6353083-B1 | CONJUGATED COPOLYMER COMPRISING UNITS DERIVED FROM 9-SUBSTITUTED FLUORENE MONOMERS AND/OR 9,9-DISUBSTITUTED FLUORENE MONOMERS AND TWO DISTINCT RESIDUAL MONOMERIC UNITS THAT HAVE HOLE TRANSPORTING PROPERTIES | THE DOW CHEMICAL COMPANY | 2002-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110175521-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ESR1 132/4885CYP19A1 1811/4885CYP11B2 1068/4885 |
| US-20100160687-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ESR1 132/4885CYP19A1 1811/4885CYP11B2 1068/4885 |
| US-20120153815-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | ARL1, RIF1, EML4 | ESR1 98/4885CYP19A1 788/4885CYP11B2 2716/4885 |
| US-20070142671-A1 | ORGANIC ELECTROLUMESCENCE DEVICE | SCO2, CHRM1, CHRM4 | ESR1 132/4885CYP19A1 1811/4885CYP11B2 1068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.